Our Approach
Founded in 2017, Fraser Healthcare LLC (“FHC”) advises a wide range of clients on new market opportunities and commercial strategies for growth. Over the past three years, FHC has partnered with Fortune 500 healthcare companies, as well as healthcare private equity firms and venture-backed healthcare companies to develop growth strategies that drive shareholder value.
Latest Publications
Betting on ‘golden age’ of colonoscopies, investors buy up gastroenterology practices
Betting on ‘golden age’ of colonoscopies, investors buy up gastroenterology practices
Special Topix – The Business of Gastroenterology (Q4.2021)
2021: A Year in Review by Spherix Global Insights and Fraser Healthcare.
Special Topix – The Business of Gastroenterology (Q3.2021)
Focus: Profile on US Gastroenterology MSOs by Spherix Global Insights and Fraser Healthcare.
Special Topix – The Business of Gastroenterology (Q2.2021)
An in-depth look at biosimilars trends and continued growth of MSOs by Spherix Global Insights and Fraser Healthcare.
Upcoming Events & Lectures
“Fraser Healthcare’s areas of expertise include gastroenterology, pulmonary remote cardiac monitoring, anesthesia, anatomic pathology, and ambulatory surgery center businesses.”
Trusted Partners
Fraser Healthcare clients include Fortune 500 healthcare companies, healthcare private equity firms, and emerging venture-backed medtech companies.